Clinicians Report That Summit 2.0™ Influenced Clinical Decision-Making in 86% of Cases; 96% Stated They Would Order the Test Again

Summit 2.0™Positive

AI Analysis

Summary

Belay Diagnostics announced publication of a peer-reviewed study in The Journal of Liquid Biopsy showing that Summit 2.0™ influenced clinical decision-making in 86% of cases and 96% of clinicians stated they would order the test again, co-authored with Johns Hopkins University School of Medicine.

Outcome Details

Peer-reviewed study published showing 86% of clinicians reported Summit 2.0™ influenced clinical decision-making and 96% stated they would order the test again

Importance:5/10

Sentiment:

0.70

diagnostic_testliquid_biopsypeer_reviewed_studyclinical_utilityacademic_partnership

Related Companies

$SHWZ

Read the original article

Published by PR Newswire Biotech on July 21, 2026 2:05 PM

Read Original